Coronavirus Update - 09th November 2020
We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.
As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.
We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our offerings to our customers.
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
